Where does Renescience A/S rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Renescience A/S ranks #33,052 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Renescience A/S hold?

Renescience A/S holds 8 US utility patents granted between 2018 and 2024, spanning 15 technology areas.

What is Renescience A/S's Innovation Score?

Renescience A/S has an Innovation Score of 40.9 out of 100 (top 34% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Renescience A/S focus on?

Renescience A/S's top technology area is Y02E (Reduction OF Greenhouse GAS [GHG] Emissions, Related TO Energy Generation, Transmission OR Distribution) with 7 patents, ranking #1,663 of 5,963 assignees active in that subclass. Grants appear in 15 CPC subclasses total.

Is Renescience A/S's patent grant rate increasing or decreasing?

Renescience A/S's recent grant velocity is +67% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Renescience A/S's patents?

Renescience A/S's patents average 17.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Renescience A/S patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Renescience A/S

USPTO PatentsView assignee record - 8 granted patents across 15 technology areas, recorded in grant years 2018–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: Y02E (Reduction OF Greenhouse GAS [GHG] Emissions, Related TO Energy Generation, Transmission OR Distribution).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Renescience ranks #33,052 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 15 technology areas.

#33,052
of 49,997 US assignees by volume: Top 34%
by Innovation Score (40.9/100): 17.9
avg claims per patent: +67%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R33052 · Foreign Corporation #33,052 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 8 grants
MID-PACK #33,052/49,997
PHOTO-FINISH Remedy Pharmaceuticals
CPC-FOCUS Y02E · 15 areas
INNOV-PAR 40.9/100
CLAIMS-RICH 17.9 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +67% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Remedy Pharmaceuticals, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Renescience’s 40.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.6 pts (19%) Velocity 8.9 pts (22%) Breadth 13.7 pts (33%) Claim depth 10.7 pts (26%)

Qualcomm Incorporated · highest

85
Renescience A/S · this assignee

41
3D Lighting… · lowest

7

What this shows Renescience's Innovation Score is 40.9/100 (top 34% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Renescience?

Each dot is one of Renescience’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Renescience’s own 17.9 claims/patent is ABOVE the 12.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Renescience vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Renescience's grants concentrate

Renescience A/S is a focused PatentsView assignee: 15 CPC subclasses with 87.5% of grants classified under Y02E (Reduction OF Greenhouse GAS [GHG] Emissions, Related TO Energy Generation, Transmission OR Distribution). Peak complete grant year is 2024 (4 grants) versus a trough of 1 in 2018. By volume, Renescience sits between Remedy Pharmaceuticals, Inc. and REV Robotics LLC.

Renescience's three-year grant acceleration

Renescience A/S shows 4 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Remedy Pharmaceut…

8
Remegen

8
Remis Gesellschaf…

8
Remo

8
Resilux

8
Respire Medical H…

8
Retinal Solutions

8
REV Robotics

8
Renescience A/S ◀

8

What this shows Renescience holds 8 patents at rank #33,007, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Renescience

By rank, the assignees closest to #33,007 in granted patent volume.

Leaders in Y02E (Reduction OF Greenhouse GAS [GHG] Emissions)

Other assignees with the most granted patents in Renescience's primary technology class.

Renescience's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 34% higher than 66% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Renescience A/S patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	1	12.5%
2019	2	25.0%
2021	1	12.5%
2024	4	50.0%

Which technologies does Renescience A/S patent most?

Y02E - Reduction OF Greenhouse GAS [GHG] Emissions, Related TO Energy Generation, Transmission OR Distribution 7

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 7

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 6

B09B - Disposal OF Solid Waste NOT Otherwise Provided FOR 4

C12Y - Enzymes 3

C05F - Organic Fertilisers NOT Covered BY Subclasses C05b, C05c, e.g. Fertilisers From Waste OR Refuse 3

C11D - Detergent COMPOSITIONS; USE OF Single Substances AS DETERGENTS; Soap OR SOAP-MAKING; Resin SOAPS; Recovery OF Glycerol 3

Y02A - Technologies FOR Adaptation TO Climate Change 3

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 2

C12R - Indexing Scheme Associated With Subclasses C12c - C12q, Relating TO Microorganisms 2

C02F - Treatment OF Water, Waste Water, Sewage, OR Sludge 2

C04B - Lime, MAGNESIA; SLAG; CEMENTS; Compositions Thereof, e.g. Mortars, Concrete OR Like Building MATERIALS; Artificial Stone ; Ceramics ; REFRACTORIES; Treatment OF Natural Stone 1

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 1

C08K - Use of inorganic or non-macromolecular organic substances as compounding ingredients 1

C08L - Compositions OF Macromolecular Compounds 1

Top 15 of 15 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Renescience A/S's patent record in context - here's where to go next.

Renescience A/S's lead technology class is Y02E (Reduction OF Greenhouse GAS [GHG] Emissions, Related TO Energy Generation, Transmission OR Distribution), 87.5% of its portfolio - see every assignee active in that class. Explore Y02E
Ranked #33,052 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Renescience A/S against Remedy Pharmaceuticals, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 40.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.